Found 21 matching trials
Saroglitazar Magnesium for the Treatment of Nonalcoholic Steatohepatitis With Fibrosis
PHASE2Saroglitazar Magnesium for the Treatment of Nonalcoholic Steatohepatitis...
A Study to Evaluate the Effect of Saroglitazar Magnesium on the QTc Interval in Healthy Volunteers
PHASE1A Single-center, Randomized, Blinded, Placebo- and Active-controlled Crosso...
Location
Cliantha Research Limited
Safety, Tolerability, and Efficacy of Saroglitazar Mg 4 mg in Liver Transplant Recipients With Nonalcoholic Fatty Liver Disease (NAFLD)
PHASE2This is a phase 2A, single center, open-label, single-arm, 24-week study to...
Location
Virginia Commonwealth University
Saroglitazar Magnesium 4 mg for Nonalcoholic Fatty Liver Disease (NAFLD) in People Living With HIV in the US
PHASE2Saroglitazar Magnesium 4 mg for NAFLD in People Living with HIV in the US...
Saroglitazar Magnesium for Treatment of Primary Biliary Cholangitis
PHASE2Saroglitazar Magnesium 1 mg and 2 mg tablets for treatment of subjects with...
A Prospective, Randomized Trial to Compare saroGLitazar With pioglitAZone in Nonalcoholic Fatty livEr Disease
PHASE3Non Alcoholic Fatty Liver Disease (NAFLD) is considered as the component of...
Long-Term Study to Evaluate the Safety and Efficacy in Participants With Primary Biliary Cholangitis of Saroglitazar Magnesium-V on Clinical Outcomes
PHASE3Long-Term Study to Evaluate the Safety and Efficacy in Participants with Pr...
A Study to Evaluate the Safety and Effectiveness of Saroglitazar 4 mg in Patients With NAFLD With Comorbidities
PHASE4A Phase 4, non-randomized, multicentre, open-label, single-arm study to eva...
Location
Gastroplus Digestive Disease Centre
Saroglitazar Magnesium in Patients With Nonalcoholic Fatty Liver Disease and/or Nonalcoholic Steatohepatitis
PHASE2This is a randomized, double-blind, placebo-controlled study in up to 104 p...
Location
Precision Research
Hepatic Impairment With Cirrhosis Due to Cholestatic Liver Disease
PHASE1A Phase 1, Open-label Extension Groups Study in Subjects having Hepatic Imp...